GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety and tolerability of GLPG0187 administered
through continuous intravenous infusion and to explore its preliminary clinical efficacy in
patients with solid tumors.